Headlines about CAS Medical Systems (NASDAQ:CASM) have trended somewhat positive on Tuesday, Accern Sentiment reports. Accern identifies positive and negative press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CAS Medical Systems earned a news sentiment score of 0.20 on Accern’s scale. Accern also gave media coverage about the medical technology company an impact score of 47.5174609128297 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Shares of CAS Medical Systems (CASM) opened at $0.69 on Tuesday. CAS Medical Systems has a 12 month low of $0.61 and a 12 month high of $1.94. The company has a current ratio of 2.46, a quick ratio of 2.12 and a debt-to-equity ratio of -0.56.
CAS Medical Systems (NASDAQ:CASM) last announced its earnings results on Thursday, November 9th. The medical technology company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.05. The business had revenue of $4.53 million for the quarter, compared to analyst estimates of $4.47 million. sell-side analysts forecast that CAS Medical Systems will post -0.36 earnings per share for the current fiscal year.
About CAS Medical Systems
CAS Medical Systems, Inc is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories.
What are top analysts saying about CAS Medical Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CAS Medical Systems Inc. and related companies.